The European patent office intends to grant another European patent for Episurf Medical, “System and method for creating a decision support material indicating damage to an anatomical joint,” addressing 3D-based assessment of joint lesions. The patent is complementary to previously approved patents within that field.
“Episurf Medical’s damage marking technology constitutes a central part of the Episealer® implant system as well as the Epioscopy® joint visualization system. Our visualization of joint damage, which includes AI-based 3D-modelling, is unique and we are building a strong patent protection around it,” said Katarina Flodström, COO.
The European patent office intends to grant another European patent for Episurf Medical, “System and method for creating a decision support material indicating damage to an anatomical joint,” addressing 3D-based assessment of joint lesions. The patent is complementary to previously approved patents within that field.
“Episurf Medical’s...
The European patent office intends to grant another European patent for Episurf Medical, “System and method for creating a decision support material indicating damage to an anatomical joint,” addressing 3D-based assessment of joint lesions. The patent is complementary to previously approved patents within that field.
“Episurf Medical’s damage marking technology constitutes a central part of the Episealer® implant system as well as the Epioscopy® joint visualization system. Our visualization of joint damage, which includes AI-based 3D-modelling, is unique and we are building a strong patent protection around it,” said Katarina Flodström, COO.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
